The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
What Clinical and Symptom Features and Comorbid Disorders Characterize Outpatients with Anxious Major Depressive Disorder: A Replication and Extension
Open accessAbstract
OBJECTIVE: We previously found that 46% of the first 1450 outpatients with depression participating in the multicentre Sequenced Treatment Alternatives to Relieve Depression (STAR*D) project qualified for the designation of anxious depression. This study was designed to replicate and extend our initial findings in a subsequent, larger cohort of outpatient STAR*D participants with nonpsychotic major depressive disorder (MDD). METHODS: Baseline clinical and sociodemographic data were collected on 2337 consecutive STAR*D participants. A baseline 17-item Hamilton Depression Rating Scale Anxiety-Somatization factor score of 7 or higher was designated as anxious depression. We identified concurrent Axis I disorders with the Psychiatric Diagnostic Screening Questionnaire (PDSQ), using a 90% specificity threshold. Depressive symptoms were assessed by clinical telephone interview with the 30-item Inventory of Depressive Symptomatology-Clinician-Rated (IDS-C30). RESULTS: The prevalence of anxious depression in this population was 45.1%. Patients with anxious MDD were significantly more likely to be in primary care settings and to be women, nonsingle, unemployed, Hispanic, less educated, and suffering from severe depression, both before and after adjustment for overall depression severity. Patients with anxious depression were significantly more likely to meet PDSQ thresholds for generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, posttraumatic stress disorder, agoraphobia, hypochondriasis, and somatoform disorder, both before and after adjusting for baseline depression severity. Individuals with anxious depression were also significantly less likely to endorse IDS-C30 items concerning atypical features and were significantly more likely to endorse items concerning melancholic-endogenous depression features, both before and after adjusting for baseline depression severity. CONCLUSIONS: This study clearly replicates our previous STAR*D findings and supports the notion that anxious depression may be a valid diagnostic subtype of MDD, with distinct psychiatric comorbidities and clinical and sociodemographic features.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Either measured with the HAM-D ASF score or HAM-A, depressed patients with anxiety symptoms generally have greater depression chronicity and severity [1,5,6], higher suicide ideation and risks [1,8,9], and lower QOL than MDD patients without anxiety.”
From Patients with anxious depression: overview of prevalence, pathophysiology and impact on course and treatment outcome (2018) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Development of a Rating Scale for Primary Depressive Illness
Hamilton, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Rush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Self-citationCUMULATIVE ILLNESS RATING SCALE
Linn, B. S., Linn, M. W., & Gurel, L. (1968) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1968.tb02103.x · Cited by 2,332
Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia
ROBINS, E., & GUZE, S. B. (1970) · American Journal of Psychiatry · doi:10.1176/ajp.126.7.983 · Cited by 2,243
The Inventory of Depressive Symptomatology (IDS): Psychometric properties
Rush, A. J., Gullion, C. M., Basco, M. R., Jarrett, R. B., & Trivedi, M. H. (1996) · Psychological Medicine · doi:10.1017/s0033291700035558 · Cited by 2,177
Self-citationMiller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990
Sequenced treatment alternatives to relieve depression (STAR*D): Rationale and design
Rush, A. J., Fava, M., Wisniewski, S. R., Lavori, P. W., Trivedi, M. H., Sackeim, H. A., Thase, M. E., Nierenberg, A. A., Quitkin, F. M., Kashner, T. M., et al. (2004) · Controlled Clinical Trials · doi:10.1016/s0197-2456(03)00112-0 · Cited by 1,076
Self-citationTRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968 · cited 1×
“The QIDS-C16 is a clinician-rated scale assessing the 9 diagnostic symptoms domains of MDD (22,23).”
MethodSelf-citationThe inventory for depressive symptomatology (IDS): Preliminary findings
Rush, A. J., Giles, D. E., Schlesser, M. A., Fulton, C. L., Weissenburger, J. E., & Burns, C. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90060-0 · Cited by 908
Self-citation
Research works printed but not linked: 7
- Fawcett J, 1983, J Clin Psychiatry, 44, 8
- Tollefson GD, 1994, J Clin Psychiatry, 55, 50
- Flint AJ, 1997, Am J Geriat Psychia, 5, 107
- Bielski RJ, 1997, Psychopharmacol Bull, 33, 75
- Miller MD, 1991, A manual of guidelines for scoring the cumulative rating scale for geriatrics (CIRS-G)
- Cleary P, 1977, Drug Exp Clin Res, 1, 115
- Fava M, 2005, Paper presented at the APA Annual Meeting;
Cited by
Sorted by citations
Fava, M., Rush, A. J., Alpert, J. E., Balasubramani, G. K., Wisniewski, S. R., Carmin, C. N., Biggs, M. M., Zisook, S., Leuchter, A., Howland, R., et al. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06111868 · Cited by 927
Self-citationFrasure-Smith, N., & Lespérance, F. (2008) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2007.4 · Cited by 571
The Association of Depression and Anxiety with Pain: A Study from NESDA
de Heer, E. W., Gerrits, M. M. J. G., Beekman, A. T. F., Dekker, J., van Marwijk, H. W. J., de Waal, M. W. M., Spinhoven, P., Penninx, B. W. J. H., & van der Feltz-Cornelis, C. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106907 · Cited by 363
Rush, A. J. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.2.201 · Cited by 356
Self-citationComorbid Anxiety and Depression: Clinical and Conceptual Consideration and Transdiagnostic Treatment
Choi, K. W., Kim, Y., & Jeon, H. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9705-0_14 · Cited by 339
Ballard, E. D., Ionescu, D. F., Vande Voort, J. L., Niciu, M. J., Richards, E. M., Luckenbaugh, D. A., Brutsché, N. E., Ameli, R., Furey, M. L., & Zarate, C. A. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.07.027 · Cited by 286
GABAB Receptors, Schizophrenia and Sleep Dysfunction
Kantrowitz, J., Citrome, L., & Javitt, D. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00001 · Cited by 258
Novel Drugs and Therapeutic Targets for Severe Mood Disorders
Mathew, S. J., Manji, H. K., & Charney, D. S. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301652 · Cited by 229
Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression
Stein, D. J., Picarel-Blanchot, F., & Kennedy, S. H. (2013) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2294 · Cited by 225
D, M. F. M., Hwang, I., Rush, A. J., Sampson, N. A., Walters, E. E., & Kessler, R. C. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.20 · Cited by 206
Self-citationDepression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial
Arnow, B. A., Blasey, C., Williams, L. M., Palmer, D. M., Rekshan, W., Schatzberg, A. F., Etkin, A., Kulkarni, J., Luther, J. F., & Rush, A. J. (2015) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.14020181 · Cited by 175
Self-citationKircanski, K., LeMoult, J., Ordaz, S. J., & Gotlib, I. H. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.08.006 · Cited by 156
NEUROBIOLOGY OF ANXIOUS DEPRESSION: A REVIEW
Ionescu, D. F., Niciu, M. J., Mathews, D. C., Richards, E. M., & Zarate, C. A. (2013) · Depression and Anxiety · doi:10.1002/da.22095 · Cited by 149
Prevalence and association of somatic symptoms in patients with Major Depressive Disorder
Vaccarino, A. L., Sills, T. L., Evans, K., & Kalali, A. H. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.01.009 · Cited by 141
Gaspersz, R., Nawijn, L., Lamers, F., & Penninx, B. W. J. H. (2018) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000376 · Cited by 139
Defining Treatment-Resistant Depression: A Comprehensive Review of the Literature
Trevino, K., McClintock, S. M., Fischer, N. M., Vora, A., & Husain, M. M. (2014) · Annals of Clinical Psychiatry · doi:10.1177/104012371402600310 · Cited by 130
Defining anxious depression: a review of the literature
Ionescu, D. F., Niciu, M. J., Henter, I. D., & Zarate, C. A. (2013) · CNS Spectrums · doi:10.1017/s1092852913000114 · Cited by 119
Supplementary dimensional assessment in anxiety disorders
Shear, M. K., Bjelland, I., Beesdo‐Baum, K., Gloster, A. T., & Wïttchen, H. (2007) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.215 · Cited by 116
Binder, E. B., Owens, M. J., Liu, W., Deveau, T. C., Rush, A. J., Trivedi, M. H., D, M. F. M., Bradley, B., Ressler, K. J., & Nemeroff, C. B. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.18 · Cited by 113
Self-citationMetabolomic and inflammatory signatures of symptom dimensions in major depression
Brydges, C. R., Bhattacharyya, S., Dehkordi, S. M., Milaneschi, Y., Penninx, B., Jansen, R., Kristal, B. S., Han, X., Arnold, M., Kastenmüller, G., et al. (2022) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2022.02.003 · Cited by 108
Self-citationRomera, I., Delgado-Cohen, H., Pérez, T., Caballero, L., & Gilaberte, I. (2008) · BMC Psychiatry · doi:10.1186/1471-244x-8-4 · Cited by 106
Riluzole in psychiatry: a systematic review of the literature
Zarate, C. A., & Manji, H. K. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.4.9.1223 · Cited by 103
Mantovani, A., Aly, M., Dagan, Y., Allart, A. M., & Lisanby, S. H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.038 · Cited by 102
Perlis, R. H., D, M. F. M., Trivedi, M. H., Alpert, J. E., Luther, J., Wisniewski, S. R., & Rush, A. J. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01298.x · Cited by 109
Self-citationDistinctive clinical characteristics and suicidal tendencies of patients with anxious depression
Seo, H.-J., Jung, Y.-E., Kim, T.-S., Kim, J.-B., Lee, M.-S., Kim, J.-M., Lim, H.-W., & Jun, T.-Y. (2011) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3182043b60 · Cited by 94
Li, H.-Y., Luo, X.-N., Ke, X.-Y., Dai, Q., Zheng, W., Zhang, C., Cassidy, R., Soares, J., Zhang, X.-Y., & Ning, Y.-P. (2017) · PLoS ONE · doi:10.1371/journal.pone.0186143 · Cited by 85
A comparison of inpatients with anxious depression to those with nonanxious depression
Lin, C., Wang, F., Lin, S., Chen, C., & Huang, C. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.08.048 · Cited by 80
Zhao, K., Liu, H., Yan, R., Hua, L., Chen, Y., Shi, J., Lu, Q., & Yao, Z. (2017) · Brain and Behavior · doi:10.1002/brb3.754 · Cited by 78
Wu, Z., Chen, J., Yuan, C., Hong, W., Peng, D., Zhang, C., Cao, L., & Fang, Y. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.03.012 · Cited by 77
Yang, W., Zhang, G., Jia, Q., Qian, Z.-K., Yin, G., Zhu, X., Alnatour, O. I., Trinh, T. H., Wu, H. E., Lang, X., et al. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.06.052 · Cited by 75
GABAB Receptors, Schizophrenia and Sleep Dysfunction
Kantrowitz, J. T., Citrome, L., & Javitt, D. C. (2009) · CNS Drugs · doi:10.2165/00023210-200923080-00005 · Cited by 73
Fiorillo, A., Dell’Osso, B. M., Albert, U., Atti, A. R., Carmassi, C., Carrà, G., Cosci, F., Vecchio, V. D., Nicola, M. D., Ferrari, S., et al. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s83130 · Cited by 69
Adherence to the EAT-Lancet diet and incident depression and anxiety
Lu, X., Wu, L., Shao, L., Fan, Y., Pei, Y., Lu, X., Borné, Y., & Ke, C. (2024) · Nature Communications · doi:10.1038/s41467-024-49653-8 · Cited by 72
Horato, N., Quagliato, L. A., & Nardi, A. E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01927-9 · Cited by 62
Howland, R. H., Wilson, M. G., Kornstein, S. G., Clayton, A. H., Trivedi, M. H., Wohlreich, M. M., & D, M. F. M. (2008) · Annals of Clinical Psychiatry · doi:10.1080/10401230802437639 · Cited by 61
Self-citationAnxiolytic effects of ascorbic acid and ketamine in mice
Fraga, D. B., Olescowicz, G., Moretti, M., Siteneski, A., Tavares, M. K., Azevedo, D., Colla, A. R. D. S., & Rodrigues, A. L. S. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.02.006 · Cited by 58
Validity of the DSM-5 anxious distress specifier for major depressive disorder
Zimmerman, M. A., Martin, J. A., McGonigal, P. T., Harris, L. M., Kerr, S., Balling, C. E., Kiefer, R., Stanton, K. J., & Dalrymple, K. L. (2018) · Depression and Anxiety · doi:10.1002/da.22837 · Cited by 64
Brain functional abnormalities in the amygdala subregions is associated with anxious depression
Qiao, J., Tao, S., Wang, X., Shi, J., Chen, Y., Tian, S., Yao, Z., & Lü, Q. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.077 · Cited by 58
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Gamble-George, J. C., Baldi, R., Halladay, L., Kocharian, A., Hartley, N., Silva, C. G., Roberts, H., Haymer, A., Marnett, L. J., Holmes, A., et al. (2016) · eLife · doi:10.7554/elife.14137 · Cited by 55
Manber, R., KRAEMER, H. C., Arnow, B. A., Trivedi, M. H., Rush, A. J., Thase, M. E., ROTHBAUM, B. O., Klein, D. N., Kocsis, J. H., Gelenberg, A. J., et al. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.3.459 · Cited by 58
Self-citationMusil, R., Seemüller, F., Meyer, S., Spellmann, I., Adli, M., Bauer, M., Kronmüller, K., Brieger, P., Laux, G., Bender, W., et al. (2017) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.1569 · Cited by 56
Anxiety Disorders: Differential Diagnosis and Their Relationship to Chronic Pain
Jordan, K. D., & Okifuji, A. (2011) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.3109/15360288.2011.596922 · Cited by 51
Comorbid anxiety increases cognitive control activation in Major Depressive Disorder
Crane, N. A., Jenkins, L. M., Dion, C., Meyers, K. K., Weldon, A. L., Gabriel, L. B., Walker, S. J., Hsu, D. T., Noll, D. C., Klumpp, H., et al. (2016) · Depression and Anxiety · doi:10.1002/da.22541 · Cited by 53
Benton, C. S., Miller, B. H., Skwerer, S., Suzuki, O., Schultz, L. E., Cameron, M. D., Marron, J. S., Pletcher, M. T., & Wiltshire, T. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2574-z · Cited by 49
Anxious depression: Clinical features and treatment
Rao, S. D. (2009) · Current Psychiatry Reports · doi:10.1007/s11920-009-0065-2 · Cited by 51
Hopwood, M. (2023) · Neurology and Therapy · doi:10.1007/s40120-023-00469-6 · Cited by 56
Daly, E., Turkoz, I., Salvadore, G., Fedgchin, M. M., Ionescu, D. F., Starr, H. L., Borentain, S., Trivedi, M. H., Thase, M. E., & Singh, J. B. (2021) · Depression and Anxiety · doi:10.1002/da.23193 · Cited by 47
Self-citationEfficacy of vilazodone on anxiety symptoms in patients with major depressive disorder
Thase, M. E., Chen, D., Edwards, J., & Ruth, A. (2014) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000045 · Cited by 49
Reliability and validity of the DSM-5 anxious distress specifier interview
Zimmerman, M., Clark, H., McGonigal, P., Harris, L., Holst, C. G., & Martin, J. (2017) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2017.02.010 · Cited by 45
Thase, M. E., Demyttenaere, K., Earley, W. R., Gustafsson, U., Udd, M., & Eriksson, H. (2012) · Depression and Anxiety · doi:10.1002/da.21970 · Cited by 44
Iorfino, F., Hickie, I. B., Lee, R. S. C., Lagopoulos, J., & Hermens, D. F. (2016) · BMC Psychiatry · doi:10.1186/s12888-016-0852-3 · Cited by 47
Cultural influences on mental health symptoms in a primary care sample of Latinx patients
Escovar, E. L., Craske, M. G., Roy‐Byrne, P., Stein, M. B., Sullivan, G., Sherbourne, C. D., Bystritsky, A., & Chavira, D. A. (2018) · Journal of Anxiety Disorders · doi:10.1016/j.janxdis.2018.03.005 · Cited by 57
Liu, W., Zhou, Y., Zheng, W., Wang, C., Zhan, Y., Lan, X., Zhang, B., Li, H., Chen, L., & Ning, Y. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.08.012 · Cited by 45
Depressive Symptom Network Associated With Comorbid Anxiety in Late-Life Depression
An, M. H., Park, S. S., You, S. C., Park, R. W., Park, B., Woo, H. K., Kim, H. K., & Son, S. J. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00856 · Cited by 41
Papakostas, G. I., Fan, H., & Tedeschini, E. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.09.009 · Cited by 43
Zhao, P., Yan, R., Wang, X., Geng, J., Chattun, M. R., Wang, Q., Yao, Z., & Lü, Q. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00994 · Cited by 40
Stein, D. J., Ahokas, A., Jarema, M., Аведисова, А. С., Vavrusova, L., Чабан, О., Gruget, C., Olivier, V., Picarel-Blanchot, F., & de Bodinat, C. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.02.007 · Cited by 41
Gollan, J. K., D, M. F. M., Kurian, B. T., Wisniewski, S. R., Rush, A. J., Daly, E., Miyahara, S., & Trivedi, M. H. (2011) · Depression and Anxiety · doi:10.1002/da.20917 · Cited by 41
Self-citationMeng, C., Feng, S., Hao, Z., Dong, C., & Liu, H. (2021) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2021.105620 · Cited by 36
Ionescu, D. F., Nugent, A. C., Luckenbaugh, D. A., Niciu, M. J., Richards, E. M., Zarate, C. A., & Furey, M. L. (2015) · Acta Neuropsychiatrica · doi:10.1017/neu.2014.46 · Cited by 34
A resting state fMRI study of major depressive disorder with and without anxiety
Li, G., Liu, P.-H., Zhang, A., Andari, E., & Zhang, K. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114697 · Cited by 33
Wu, H., Li, T., Peng, C., Yang, C., Bian, Y., Li, X., Xiao, Q., Wang, P., Zhang, Z., & Zhang, Y. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.024 · Cited by 32
Chan, H. N., Rush, A. J., Nierenberg, A. A., Trivedi, M., Wisniewski, S. R., Balasubramani, G. K., Friedman, E. S., Gaynes, B. N., Davis, L., Morris, D., et al. (2012) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001660 · Cited by 30
Self-citationBaek, J. H., Kim, H., D, M. F. M., Mischoulon, D., Papakostas, G. I., Nierenberg, A. A., Heo, J.-Y., & Jeon, H. J. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.3.321 · Cited by 33
Recognition of emotional facial expressions in anxious and nonanxious depression
Berg, H. E., Ballard, E. D., Luckenbaugh, D. A., Nugent, A. C., Ionescu, D. F., & Zarate, C. A. (2016) · Comprehensive Psychiatry · doi:10.1016/j.comppsych.2016.06.007 · Cited by 32
Characterization of depressed bipolar patients with current suicidal ideation
Nobile, B., Dubois, J., Aouizerate, B., Aubin, V., Loftus, J., Bellivier, F., Belzeaux-R, R., Dubertret, C., Gard, S., Haffen, É., et al. (2020) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867420963744 · Cited by 30
Friedman, E. S., Wisniewski, S. R., Gilmer, W. S., Nierenberg, A. A., Rush, A. J., D, M. F. M., Zisook, S., Balasubramani, G. K., & Trivedi, M. H. (2009) · Depression and Anxiety · doi:10.1002/da.20568 · Cited by 29
Self-citationOutcomes of Acute Phase Cognitive Therapy in Outpatients with Anxious versus Nonanxious Depression
Smits, J. A. J., Minhajuddin, A., Thase, M. E., & Jarrett, R. B. (2012) · Psychotherapy and Psychosomatics · doi:10.1159/000334909 · Cited by 32
Wu, Z., Cao, L., Peng, D., Mellor, D. J., Zhang, C., Li, H., Wang, Z., Song, Y., Li, C., & Fang, Y. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.07.019 · Cited by 28
D’Avanzato, C., Martinez, J. H., Attiullah, N., Friedman, M., Toba, C., Boerescu, D. A., & Zimmerman, M. A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.040 · Cited by 28
What is anxious depression? Overlap and agreement between different definitions
Zimmerman, M. A., Kerr, S., Kiefer, R., Balling, C. E., & Dalrymple, K. L. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.11.028 · Cited by 26
Clinical differences between early and late remission in depressive patients
Roca, M., Garcı́a-Toro, M., García‐Campayo, J., Vives, M., Armengol, S., García-García, M., Asensio, D., & Gili, M. (2011) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.05.051 · Cited by 25
Papakostas, G. I., Clain, A. J., Ameral, V., Baer, L., Brintz, C., Smith, W. T., Londborg, P. D., Glaudin, V., Painter, J. R., & D, M. F. M. (2009) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32833205a4 · Cited by 24
Ma, J., Chen, Y., Wang, Z., Wang, R., & Dong, Y. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105710 · Cited by 25
Dean, K. E., Long, A. C. J., Trinh, N., McClendon, J., & Buckner, J. D. (2022) · Behavior Therapy · doi:10.1016/j.beth.2022.04.005 · Cited by 24
Zhao, P., Wang, X., Wang, Q., Yan, R., Chattun, M. R., Yao, Z., & Lü, Q. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-05364-w · Cited by 24
Suthoff, E. D., Kosinski, M. R., Arnaud, A. M., Hodgkins, P., Gunduz‐Bruce, H., Lasser, R. A., Silber, C., Sankoh, A. J., Li, H., WERNEBURG, B. G., et al. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.03.068 · Cited by 24
Trevizol, A. P., Downar, J. H., Vila‐Rodriguez, F., Konstantinou, G., Daskalakis, Z. J., & Blumberger, D. M. (2020) · Depression and Anxiety · doi:10.1002/da.23125 · Cited by 21
Petersen, T., Andreotti, C., Chelminski, I., Young, D., & Zimmerman, M. A. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.036 · Cited by 23
Efficacy of venlafaxine extended release in major depressive disorder patients
Lyndon, G. J., Prieto, R., Wajsbrot, D., Allgulander, C., & Bandelow, B. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000256 · Cited by 24
Advance in Diagnosis of Depressive Disorder
Fang, Y., & Wu, Z. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9271-0_9 · Cited by 21
Luo, G., Li, Y., Yao, C., Li, M., Li, J., & Zhang, X. (2023) · Journal of Affective Disorders · doi:10.1016/j.jad.2023.05.008 · Cited by 18
Shim, E., Hwang, H., Lee, K.-M., Lee, J.-Y., Lee, S. D., Baik, M., Shin, M., Moon, H., & Hahm, B. (2020) · Psychiatry Research · doi:10.1016/j.psychres.2020.112912 · Cited by 21
Angstman, K. B., DeJesus, R. S., & Rohrer, J. E. (2010) · PubMed Central · Cited by 19
Zhou, Y., Wang, Q., Ren, H., Yang, W. F. Z., Ma, Y., Wu, Q., Luo, Y., Yang, D. H., Liu, T., & Zhang, X. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2022.08.018 · Cited by 19
Boulenger, J.-P., Hermès, A., Huusom, A. K. T., & Weiller, E. (2010) · Current Medical Research and Opinion · doi:10.1185/03007990903482467 · Cited by 19
Zimmerman, M. A., Clark, H., McGonigal, P. T., Harris, L. M., Holst, C. G., & Martin, J. A. (2018) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000000767 · Cited by 18
Xia, W., Zhou, R., Zhao, G., Wang, F., Mao, R., Peng, D., Yang, T., Wang, Z., Chen, J., & Fang, Y. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s169583 · Cited by 18
FAWCETT, J. A. (2013) · Depression and Anxiety · doi:10.1002/da.22058 · Cited by 20
Blockade of NOP receptor modulates anxiety-related behaviors in mice exposed to inescapable stress
Silva, A. I., Holanda, V. A. D., Neto, J. A., Silva, E. D., Soares-Rachetti, V. D. P., Calò, G., Ruzza, C., & Gavioli, E. C. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05487-y · Cited by 17
Tundo, A., Musetti, L., de Filippis, R., Grande, C. D., Falaschi, V., Proietti, L., & Dell’Osso, L. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.024 · Cited by 17
Comorbid anxiety and depression psychopathology in university students: a network approach
Makhubela, M. S. (2020) · South African Journal of Psychology · doi:10.1177/0081246320973839 · Cited by 18
Kornstein, S. G., Guico‐Pabia, C. J., & Fayyad, R. S. (2014) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2427 · Cited by 16
Optimal zone for bandwidth selection in semiparametric models
Li, J., Zhang, W., & Wu, Z. (2011) · Journal of nonparametric statistics · doi:10.1080/10485252.2010.533768 · Cited by 16
Lin, C., Yen, Y., Chen, M., & Chen, C. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.08.003 · Cited by 16
Gong, L., He, C., Yin, Y., Wang, H. Z., Ye, Q., Bai, F., Yuan, Y., Zhang, H., Lv, L., Zhang, H., et al. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00292 · Cited by 16
Cancino, A., Bianchi, M. L., Serrano, C., Ballesteros, S., Cáceres, C., & Vitriol, V. G. (2018) · Depression Research and Treatment · doi:10.1155/2018/1701978 · Cited by 16
Braund, T. A., Palmer, D. M., Williams, L. M., & Harris, A. W. (2019) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867419835933 · Cited by 15
Otsubo, T., Hokama, C., SANO, N., Watanabe, Y., Kikuchi, T., & Tanaka, K. (2021) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2021.1907415 · Cited by 16
Treatment Options for the Patient Who Does Not Respond Well to Initial Antidepressant Therapy
Preskorn, S. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000351880.30013.2a · Cited by 15
Metadata
- Authors
- Fava, M., Rush, A. J., Alpert, J. E., Carmin, C. N., Balasubramani, G., Wisniewski, S. R., Trivedi, M. H., Biggs, M. M., & Shores-Wilson, K.
- Affiliations
- Associate Chief of Psychiatry for Clinical Research, Massachusetts General Hospital, Boston, Massachusetts; Director, Depression Clinical and Research Program, Massachusetts General Hospital, Boston, Massachusetts; Professor of Psychiatry, Harvard Medical School, Boston, Massachussets
- The University of Texas Southwestern Medical Center (US)
- Massachusetts General Hospital (US)
- University of Illinois Chicago (US)
- Research Associate, Epidemiology Data Center, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania
- University of Pittsburgh (US)
- Associate Professor, The University of Texas Southwestern Medical Center, Department of Psychiatry and Department of Family and Community Medicine, Dallas, Texas
- Venue
- The Canadian Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2006-11
- Volume
- 51
- Issue
- 13
- Pages
- 823-835
- ISSN
- 0706-7437 (ISSN-L)
- 1497-0015
- OpenAlex
- W1505466667
- Cited by
- 183
- References
- 32
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 11 · 2023: 10 · 2022: 10 · 2021: 7 · 2020: 13 · 2019: 9 · 2018: 15 · 2017: 8 · 2016: 9 · 2015: 5 · 2014: 9 · 2013: 9 · 2012: 7
- FWCI
- 10.51
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Canadian Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Health and Human Services (N01MH90003)
- National Institutes of Health (n01mh90003-26-0-0)
- National Institute of Mental Health (N01‐MH‐90003)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Keywords
- anxious depression, major depressive disorder, psychiatric comorbidity, generalized anxiety disorder, panic disorder, obsessive-compulsive disorder, post-traumatic stress disorder, agoraphobia, health anxiety, somatoform disorders, endogenous depression, atypical depression, depression severity, sociodemographic factors, STAR*D, outpatient depression, diagnostic subtypes
- MeSH terms
- Adolescent, Adult, Aged, Ambulatory Care, Anxiety Disorders, Depressive Disorder, Major, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Primary Health Care, Prospective Studies, Comorbidity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review